Elisa Maldonado-Holmertz is the current advisor at TeVido BioDevices. Elisa has also worked as an account manager at Porter Novelli, a global health and wellness company. In this role, they were responsible for healthcare writing for McNeil, Pfizer, Ethicon, and TransCelerate. Prior to that, Maldonado-Holmertz was the vice president of USA operations at Emergo Group. In this role, they were responsible for marketing and sales for the company. Before Emergo Group, Maldonado-Holmertz worked as a reimbursement and market access manager for Synergus Corp and Aerocrine. In these roles, they were responsible for managing the company's reimbursement process and market access. Maldonado-Holmertz began their career in clinical development, working as a manager for Pharmacia (Pfizer) and Pharmaco (PPD).
Elisa Maldonado-Holmertz has a diploma in business management from Henley Business School, a certificate in health economics of pharmaceutical and other medical interventions from the European School of Health Economics (EHE), and a bachelor of arts (BA) in psychology from The University of Texas at Austin.